Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology

Abstract Cancer is a major threat to human health. Among various treatment methods, precision therapy has received significant attention since the inception, due to its ability to efficiently inhibit tumor growth, while curtailing common shortcomings from conventional cancer treatment, leading towar...

Full description

Bibliographic Details
Main Authors: Jingjing Yang, Anthony Griffin, Zhe Qiang, Jie Ren
Format: Article
Language:English
Published: Nature Publishing Group 2022-11-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-022-01243-0
_version_ 1797983944417738752
author Jingjing Yang
Anthony Griffin
Zhe Qiang
Jie Ren
author_facet Jingjing Yang
Anthony Griffin
Zhe Qiang
Jie Ren
author_sort Jingjing Yang
collection DOAJ
description Abstract Cancer is a major threat to human health. Among various treatment methods, precision therapy has received significant attention since the inception, due to its ability to efficiently inhibit tumor growth, while curtailing common shortcomings from conventional cancer treatment, leading towards enhanced survival rates. Particularly, organelle-targeted strategies enable precise accumulation of therapeutic agents in organelles, locally triggering organelle-mediated cell death signals which can greatly reduce the therapeutic threshold dosage and minimize side-effects. In this review, we comprehensively discuss history and recent advances in targeted therapies on organelles, specifically including nucleus, mitochondria, lysosomes and endoplasmic reticulum, while focusing on organelle structures, organelle-mediated cell death signal pathways, and design guidelines of organelle-targeted nanomedicines based on intervention mechanisms. Furthermore, a perspective on future research and clinical opportunities and potential challenges in precision oncology is presented. Through demonstrating recent developments in organelle-targeted therapies, we believe this article can further stimulate broader interests in multidisciplinary research and technology development for enabling advanced organelle-targeted nanomedicines and their corresponding clinic translations.
first_indexed 2024-04-11T06:55:06Z
format Article
id doaj.art-e5501bef0e5244d2807cd4b1e1459eb8
institution Directory Open Access Journal
issn 2059-3635
language English
last_indexed 2024-04-11T06:55:06Z
publishDate 2022-11-01
publisher Nature Publishing Group
record_format Article
series Signal Transduction and Targeted Therapy
spelling doaj.art-e5501bef0e5244d2807cd4b1e1459eb82022-12-22T04:39:04ZengNature Publishing GroupSignal Transduction and Targeted Therapy2059-36352022-11-017112710.1038/s41392-022-01243-0Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncologyJingjing Yang0Anthony Griffin1Zhe Qiang2Jie Ren3Institute of Nano and Biopolymeric Materials, School of Materials Science and Engineering, Tongji UniversitySchool of Polymer Science and Engineering, University of Southern MississippiSchool of Polymer Science and Engineering, University of Southern MississippiInstitute of Nano and Biopolymeric Materials, School of Materials Science and Engineering, Tongji UniversityAbstract Cancer is a major threat to human health. Among various treatment methods, precision therapy has received significant attention since the inception, due to its ability to efficiently inhibit tumor growth, while curtailing common shortcomings from conventional cancer treatment, leading towards enhanced survival rates. Particularly, organelle-targeted strategies enable precise accumulation of therapeutic agents in organelles, locally triggering organelle-mediated cell death signals which can greatly reduce the therapeutic threshold dosage and minimize side-effects. In this review, we comprehensively discuss history and recent advances in targeted therapies on organelles, specifically including nucleus, mitochondria, lysosomes and endoplasmic reticulum, while focusing on organelle structures, organelle-mediated cell death signal pathways, and design guidelines of organelle-targeted nanomedicines based on intervention mechanisms. Furthermore, a perspective on future research and clinical opportunities and potential challenges in precision oncology is presented. Through demonstrating recent developments in organelle-targeted therapies, we believe this article can further stimulate broader interests in multidisciplinary research and technology development for enabling advanced organelle-targeted nanomedicines and their corresponding clinic translations.https://doi.org/10.1038/s41392-022-01243-0
spellingShingle Jingjing Yang
Anthony Griffin
Zhe Qiang
Jie Ren
Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
Signal Transduction and Targeted Therapy
title Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
title_full Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
title_fullStr Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
title_full_unstemmed Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
title_short Organelle-targeted therapies: a comprehensive review on system design for enabling precision oncology
title_sort organelle targeted therapies a comprehensive review on system design for enabling precision oncology
url https://doi.org/10.1038/s41392-022-01243-0
work_keys_str_mv AT jingjingyang organelletargetedtherapiesacomprehensivereviewonsystemdesignforenablingprecisiononcology
AT anthonygriffin organelletargetedtherapiesacomprehensivereviewonsystemdesignforenablingprecisiononcology
AT zheqiang organelletargetedtherapiesacomprehensivereviewonsystemdesignforenablingprecisiononcology
AT jieren organelletargetedtherapiesacomprehensivereviewonsystemdesignforenablingprecisiononcology